COAVE THERAPEUTICS
Live / Registered — Registered (as of 14 Mar 2023)
What this means for you
Registered since 14 Mar 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97197299
- Registration number
- 6999420
- Mark type
- Stylized text
- Filed
- 30 Dec 2021
- Published for opposition
- 27 Dec 2022
- Registered
- 14 Mar 2023
- Attorney of record
- Pina Campagna
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations in the nature of viral systems, gene therapy systems, and nucleic acid delivery systems comprised of viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells used to deliver modified genetic material into other cells for medical purposes for the diagnosis, treatment or prevention of ophthalmological disorders, diseases of the central and peripheral nervous system, hereditary disorders, genetic disorders and disorders of monogenic origin; Pharmaceutical preparations and products in the nature of genetically modified cells for use in gene therapy for medical purposes; Pharmaceutical preparations, namely, vaccines, prophylactic pharmaceuticals in the nature of antigens, and other genetically modified pharmaceuticals cells or tissue for use in nucleic acid therapy, gene therapy and cell therapy; Drug delivery agents in the nature genetically modified compounds for medical, pharmaceutical or veterinary purposes; Biological tissue cultures for medical purposes; Chemical or biological reagents for medical, pharmaceutical or veterinary purposes, namely, for nucleic acid therapy, gene therapy and cell therapy; Biological preparations for medical, pharmaceutical or veterinary purposes, namely, for use in connection with medical and clinical gene therapy, nucleic acid therapy and cell therapy to diagnose, treat and prevent ophthalmological disorders, diseases of the central and peripheral nervous system, hereditary disorders, genetic disorders and disorders of monogenic origin
- Class 042 — Scientific and technological services: Product research and development in the fields of biotechnology, biology, biomedicine, pharmacy, medical sciences, gene therapy, chemistry and biochemistry; Biological, biomedical and pharmaceutical therapeutic research services; Research in the fields of pharmaceutical and biological therapeutic preparations, namely, gene therapy and nucleic acid delivery systems for use in clinical trials and post-marketing trials; Pharmaceutical research and development; Provision of scientific research information in the fields of pharmaceuticals, biomedicine, gene therapy, clinical trials and post-marketing trials; Biological research; Chemical analysis and research services; Providing medical and scientific research information in the field of clinical trials; conducting clinical trials for others; Medical research services
Owner
- Coave Therapeutics, Paris, FR
- Coave Therapeutics, Paris, FR
- Coave Therapeutics, Paris, FR
Prosecution history
- 14 Mar 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Mar 2023 — REGISTERED-PRINCIPAL REGISTER
- 27 Dec 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Dec 2022 — PUBLISHED FOR OPPOSITION
- 07 Dec 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Nov 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Nov 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 21 Nov 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 21 Nov 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 04 Oct 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 04 Oct 2022 — NON-FINAL ACTION E-MAILED
- 04 Oct 2022 — NON-FINAL ACTION WRITTEN
- 04 Oct 2022 — ASSIGNED TO EXAMINER
- 05 Jan 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 03 Jan 2022 — NEW APPLICATION ENTERED